Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 109
Filter
1.
Curr Oncol ; 25(6): 366-370, 2018 12.
Article in English | MEDLINE | ID: mdl-30607110

ABSTRACT

Background: We aimed to assess current treatment patterns and outcomes in elderly patients with localized gastric and esophageal (ge) cancers. Methods: This retrospective analysis considered patients 75 years of age or older with ge cancers treated during 2012-2014. Patient demographics and tumour characteristics were collected. Overall survival (os) and disease-free survival were assessed by univariable and multivariable Cox proportional hazards regression, adjusting for demographics. Logistic regression analyses were used to examine factors affecting treatment choices. Results: The 110 patients in the study cohort had a median age of 81 years (range: 75-99 years). Primary disease sites were esophageal (55%) and gastric (45%). Treatment received included radiation therapy alone (29%), surgery alone (26%), surgery plus perioperative therapy (14%), chemoradiation alone (10%), and supportive care alone (14%). In multivariable analyses, surgery (hazard ratio: 0.48; 95% confidence interval: 0.26 to 0.90; p = 0.02) was the only independent predictor for improved os. Patients with a good Eastern Cooperative Oncology Group performance status (p = 0.008), gastric disease site (p = 0.02), and adenocarcinoma histology (p = 0.01) were more likely to undergo surgery. Conclusions: At our institution, few patients 75 years of age and older received multimodality therapy for localized ge cancers. Outcomes were better for patients who underwent surgery than for those who did not. To ensure optimal treatment selection, comprehensive geriatric assessment should be considered for patients 75 years of age and older with localized ge cancers.


Subject(s)
Esophageal Neoplasms/therapy , Stomach Neoplasms/therapy , Aged , Aged, 80 and over , Esophageal Neoplasms/pathology , Female , Humans , Male , Retrospective Studies , Stomach Neoplasms/pathology , Treatment Outcome
2.
Cytopathology ; 25(4): 250-8, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24261323

ABSTRACT

OBJECTIVE: To review cytomorphological criteria and clinicopathological findings in combination with ancillary tests for the specific diagnosis of pulmonary marginal zone lymphoma (MZL) in fine needle aspiration (FNA) specimens. METHODS: Cases of pulmonary MZL diagnosed using cytological specimens from 2005 to 2012 were retrieved and reviewed by three cytopathologists. Results of immunophenotypic analysis, interphase fluorescence in situ hybridization (FISH) and molecular assays were collated, together with clinical information and imaging data. Concurrent surgical biopsies were also retrieved. RESULTS: Fifteen lung FNA specimens were identified. The smears consisted predominantly of small centrocyte-like cells. Marked plasma cell differentiation was evident in 11 cases. All cases with slides available showed tissue fragments with lymphoid tangles (TFLTs). Multinucleated giant cells were present in nine cases, two of which showed granulomas. Immunophenotyping confirmed B-cell clonality in all cases. B-cell clonality was detected by polymerase chain reaction (PCR) in two samples. FISH identified MALT1 translocation in four of 10 cases tested and trisomy 3 in three of four cases. Concurrent surgical biopsies were diagnosed independently as MZL in seven cases. CONCLUSIONS: Cytology smears from lung FNA samples consisting of small lymphoid cells with a relative abundance of plasma cells or plasmacytoid cells and large TFLTs should prompt immunophenotyping and other ancillary studies, even if multinucleated giant cells and poorly formed granulomas are also identified. Specific diagnosis of pulmonary MZL in FNA samples can be rendered on the basis of morphological features coupled with the demonstration of B-cell clonality by immunophenotyping or PCR and cytogenetic abnormalities by FISH.


Subject(s)
Biopsy, Fine-Needle , Lung/pathology , Lymphoma, B-Cell, Marginal Zone/diagnosis , Adult , Aged , Aged, 80 and over , Caspases/biosynthesis , Caspases/isolation & purification , Female , Humans , Immunophenotyping , In Situ Hybridization, Fluorescence , Lymphoma, B-Cell, Marginal Zone/genetics , Lymphoma, B-Cell, Marginal Zone/pathology , Male , Middle Aged , Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 Protein , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/isolation & purification
3.
Am J Transplant ; 13(6): 1441-9, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23668775

ABSTRACT

We compared cold static with acellular normothermic ex vivo liver perfusion (NEVLP) as a novel preservation technique in a pig model of DCD liver injury. DCD livers (60 min warm ischemia) were cold stored for 4 h, or treated with 4 h cold storage plus 8 h NEVLP. First, the livers were reperfused with diluted blood as a model of transplantation. Liver injury was determined by ALT, oxygen extraction, histology, bile content analysis and hepatic artery (HA) angiography. Second, AST levels and bile production were assessed after DCD liver transplantation. Cold stored versus NEVLP grafts had higher ALT levels (350 ± 125 vs. 55 ± 35 U/L; p < 0.0001), decreased oxygen extraction (250 ± 65 mmHg vs. 410 ± 58 mmHg, p < 0.01) and increased hepatocyte necrosis (45% vs. 10%, p = 0.01). Levels of bilirubin, phospholipids and bile salts were fivefold decreased, while LDH was sixfold higher in cold stored versus NEVLP grafts. HA perfusion was decreased (twofold), and bile duct necrosis was increased (100% vs. 5%, p < 0.0001) in cold stored versus NEVLP livers. Following transplantation, mean serum AST level was higher in the cold stored versus NEVLP group (1809 ± 205 U/L vs. 524 ± 187 U/L, p < 0.05), with similar bile production (2.5 ± 1.2 cc/h vs. 2.8 ± 1.4 cc/h; p = 0.2). NEVLP improved HA perfusion and decreased markers of liver duct injury in DCD grafts.


Subject(s)
Bile Duct Diseases/prevention & control , Brain Death , Liver Transplantation , Organ Preservation/methods , Perfusion/methods , Reperfusion Injury/prevention & control , Angiography , Animals , Bile Duct Diseases/diagnostic imaging , Disease Models, Animal , Male , Reperfusion Injury/diagnostic imaging , Swine , Temperature , Tomography, X-Ray Computed
4.
Rofo ; 183(9): 842-8, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21830181

ABSTRACT

PURPOSE: To retrospectively evaluate the quality and complications of CT-guided biopsies and their impact on treatment. MATERIALS AND METHODS: A total of 265 CT-guided interventions performed during a 6-month period were extracted by digital database query. These included 127 CT-guided biopsies, which were classified by patient age, organ/body area, histopathological biopsy diagnosis, complications, and performing physician. RESULTS: In 51 % of cases (65 / 127), CT-guided biopsies led to a malignant diagnosis and a change in the patient's treatment. Retrospectively, complications were to be expected in a range of 12 - 26 %, given a 95 % confidence interval. In terms of organ/body area, most complications occurred in lung biopsies (23 / 56; 41 %). 80 % of CT-guided biopsies were performed without complications. 2 of the 11 physicians performed 66 % of all biopsies (84 / 127) and had significantly fewer complications than the others. Patient age was a statistically significant factor for complications (p < 0.018) as well as for a malignant biopsy diagnosis (p < 0.009). CONCLUSION: Our initial quality control assessment suggests that frequent use of CT-guided biopsy by the performing physician rather than the general level of experience is associated with fewer complications for patients. Age is a significant factor for complications of CT-guided biopsies, thus leading to an increased risk/benefit ratio. As expected, age also significantly increases the risk of a malignant biopsy result. Complications and malignant biopsy results were not significantly associated. CT-guided biopsies triggered a change in treatment in over 50 % of cases.


Subject(s)
Biopsy, Needle/adverse effects , Biopsy, Needle/standards , Neoplasms/pathology , Quality Indicators, Health Care/standards , Radiography, Interventional/standards , Surgery, Computer-Assisted/adverse effects , Surgery, Computer-Assisted/standards , Tomography, X-Ray Computed/adverse effects , Tomography, X-Ray Computed/standards , Adult , Aged , Biopsy, Needle/instrumentation , Clinical Competence/standards , Female , Germany , Humans , Male , Middle Aged , Neoplasms/diagnostic imaging , Quality Control , Radiography, Interventional/instrumentation , Retrospective Studies , Sensitivity and Specificity , Surgery, Computer-Assisted/instrumentation , Tomography, X-Ray Computed/instrumentation
5.
Br J Surg ; 97(3): 337-43, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20095017

ABSTRACT

BACKGROUND: Mediastinal ectopic parathyroid adenoma is a frequent cause of persistent or recurrent hyperparathyroidism, traditionally treated by open surgery. Thoracoscopic access is associated with reduced morbidity in mediastinal surgery. The aim of this study was to evaluate the feasibility and effectiveness of robot-assisted dissection for mediastinal ectopic parathyroid glands. METHODS: Two patients with recurrent secondary hyperparathyroidism and three with complicated primary hyperparathyroidism were operated on between July 2004 and August 2008 for ectopic mediastinal parathyroid glands. Fusion of single-photon emission computed tomography and computed tomography led to an exact identification of the culprit glands. Surgery was performed thoracoscopically with the da Vinci robotic system using a three-trocar approach. RESULTS: All procedures were completed successfully with the robotic system. No perioperative morbidity or mortality was noted. Median operating time was 58 (range 42-125) min. Intraoperative parathyroid hormone reduction indicated complete resection. Median hospital stay was 3 (range 2-4) days. CONCLUSION: Robot-assisted dissection is a promising approach for resection of ectopic parathyroid glands in remote narrow anatomical locations such as the mediastinum.


Subject(s)
Adenoma/surgery , Mediastinal Neoplasms/surgery , Parathyroid Glands/surgery , Parathyroid Neoplasms/surgery , Robotics , Adult , Feasibility Studies , Female , Humans , Intraoperative Care , Male , Middle Aged , Parathyroidectomy/methods , Preoperative Care , Tomography, Emission-Computed, Single-Photon , Tomography, X-Ray Computed
6.
Zentralbl Chir ; 134(4): 331-7, 2009 Aug.
Article in German | MEDLINE | ID: mdl-19688682

ABSTRACT

INTRODUCTION: Redo surgery or reintervention following conventional or endovascular aortoiliac reconstruction often requires exclusion of new aneurysms. In the present study the potentials of endovascular management of such lesions are investigated. METHODS: All patients with endovascular reoperation for of newly developed aortoiliac aneurysms were identified from a prospectively run data-base. The indications and results of endovascular therapy were analysed retrospectively. In detail, data were analysed for the type of original operation, interval until and kind of reoperation, and results concerning survival, technical success and complications. RESULTS: From 12 / 2003 through 3 / 2007 195 patients with aortoiliac aneurysms were operated. Endovascular repair was performed in 15 cases of previously excluded aneurysms. Mean age of these 15 patients (12 men) was 73 (64-85) years. Ten patients had a primary conventional (group A) and 5 patients had a primary endovascular (group B) aneurysm repair. The mean time interval between the first and second operation was 8.9 (1-26) years. The secondary endovascular therapy in group A was successful in all cases. In group B endoleaks type I a (n = 1), I a / b (n = 1), II (n = 2) and III (n = 1) were treated. One type II endoleak could only be treated successfully by conversion to open repair, the other one was successfully treated by reintervention. All but one patient are alive and -remained free of pathological findings during a median follow-up of 13 (2-39) months. DISCUSSION: Because of the clearly elevated operation risk of redo surgery after conventional or endovascular aneurysm repair, endovascular aneurysm exclusion represents the method of first choice. The reasonable selection and combination of procedures allows for an optimal adaptation of therapy to the individual case.


Subject(s)
Angioplasty/methods , Aortic Aneurysm, Abdominal/surgery , Blood Vessel Prosthesis , Iliac Artery , Postoperative Complications/surgery , Stents , Aged , Aged, 80 and over , Angiography, Digital Subtraction , Aortic Aneurysm, Abdominal/diagnosis , Aortic Rupture/diagnosis , Aortic Rupture/surgery , Aortography , Female , Follow-Up Studies , Graft Occlusion, Vascular/diagnosis , Graft Occlusion, Vascular/surgery , Humans , Male , Middle Aged , Postoperative Complications/diagnosis , Prospective Studies , Prosthesis Design , Recurrence , Reoperation , Tomography, X-Ray Computed , Ultrasonography, Doppler, Color
7.
Rofo ; 181(11): 1056-64, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19536726

ABSTRACT

PURPOSE: To evaluate the impact of dose reduction on the performance of computer-aided lung nodule detection systems (CAD) of two manufacturers by comparing respective CAD results on ultra-low-dose computed tomography (ULD-CT) and standard dose CT (SD-CT). MATERIALS AND METHODS: Multi-slice computed tomography (MSCT) data sets of 26 patients (13 male and 13 female, patients 31 - 74 years old) were retrospectively selected for CAD analysis. Indication for CT examination was staging of a known primary malignancy or suspected pulmonary malignancy. CT images were consecutively acquired at 5 mAs (ULD-CT) and 75 mAs (SD-CT) with 120 kV tube voltage (1 mm slice thickness). The standard of reference was determined by three experienced readers in consensus. CAD reading algorithms (pre-commercial CAD system, Philips, Netherlands: CAD-1; LungCARE, Siemens, Germany: CAD-2) were applied to the CT data sets. RESULTS: Consensus reading identified 253 nodules on SD-CT and ULD-CT. Nodules ranged in diameter between 2 and 41 mm (mean diameter 4.8 mm). Detection rates were recorded with 72 % and 62 % (CAD-1 vs. CAD-2) for SD-CT and with 73 % and 56 % for ULD-CT. Median false positive rates per patient were calculated with 6 and 5 (CAD-1 vs. CAD-2) for SD-CT and with 8 and 3 for ULD-CT. After separate statistical analysis of nodules with diameters of 5 mm and greater, the detection rates increased to 83 % and 61 % for SD-CT and to 89 % and 67 % for ULD-CT (CAD-1 vs. CAD-2). For both CAD systems there were no significant differences between the detection rates for standard and ultra-low-dose data sets (p > 0.05). CONCLUSION: Dose reduction of the underlying CT scan did not significantly influence nodule detection performance of the tested CAD systems.


Subject(s)
Diagnosis, Computer-Assisted/methods , Image Processing, Computer-Assisted/methods , Solitary Pulmonary Nodule/diagnostic imaging , Tomography, Spiral Computed/methods , Adult , Aged , Contrast Media , Female , Humans , Iohexol/analogs & derivatives , Lung/diagnostic imaging , Male , Middle Aged , Radiation Dosage , Sensitivity and Specificity , Solitary Pulmonary Nodule/classification
8.
Rofo ; 181(1): 24-31, 2009 Jan.
Article in English | MEDLINE | ID: mdl-19085687

ABSTRACT

PURPOSE: To compare the interobserver variability of the unidimensional diameter and volume measurements of pulmonary nodules in an intrascan and interscan analysis using semi-automated segmentation software on ultra-low-dose computed tomography (ULD-CT) and standard dose CT (SD-CT) data. MATERIALS AND METHODS: In 33 patients with pulmonary nodules, two chest multi-slice CT (MSCT) datasets (1 mm slice thickness; 20 % reconstruction overlap) had been consecutively acquired with an ultra-low dose (120 kV, 5 mAs) and standard dose technique (120 kV, 75 mAs). MSCT data was retrospectively analyzed using the segmentation software OncoTREAT (MeVis, Bremen, Germany, version 1.3). The volume of 229 solid pulmonary nodules included in the analysis as well as the largest diameter according to RECIST (Response Evaluation Criteria for Solid Tumors) were measured by two radiologists. Interobserver variability was calculated and SD-CT and ULD-CT data compared in an intrascan and interscan analysis. RESULTS: The median nodule diameter (n = 229 nodules) was registered with 8.2 mm (range: 2.8 to 43.6 mm, mean: 10.8 mm). The nodule volume ranged between 0.01 and 49.1 ml (median 0.1 ml, mean 1.5 ml). With respect to interobserver variability, the intrascan analysis did not reveal statistically significant differences (p > 0.05) between ULD-CT and SD-CT with broader limits of agreement for relative differences of RECIST measurements (-31.0 % + 27.0 % mean -2.0 % for SD-CT; -27.0 % + 38.6 %, mean 5.8 % for ULD-CT) than for volume measurements (-9.4 %, 8.0 %, mean 0.7 % for SD-CT; -13 %, 13 %, mean 0.0 % for ULD-CT). The interscan analysis showed broadened 95 % confidence intervals for volume measurements (-26.5 % 29.1 % mean 1.3 %, and -25.2 %, 29.6 %, mean 2.2 %) but yielded comparable limits of agreement for RECIST measurements. CONCLUSION: The variability of nodule volumetry assessed by semi-automated segmentation software as well as nodule size determination by RECIST appears to be independent of the acquisition dose in the CT source dataset. This is particularly important regarding size determination of pulmonary nodules in screening trials using low-dose CT data for follow-up imaging.


Subject(s)
Carcinoma, Renal Cell/secondary , Cone-Beam Computed Tomography/methods , Image Processing, Computer-Assisted/methods , Lung Neoplasms/diagnostic imaging , Sarcoma/secondary , Solitary Pulmonary Nodule/diagnostic imaging , Tomography, Spiral Computed/methods , Carcinoma, Renal Cell/diagnostic imaging , Carcinoma, Renal Cell/pathology , Computer Graphics , Humans , Kidney Neoplasms/diagnostic imaging , Lung/diagnostic imaging , Lung/pathology , Lung Neoplasms/pathology , Lung Neoplasms/secondary , Neoplasm Staging , Observer Variation , Radiation Dosage , Retrospective Studies , Sarcoma/diagnostic imaging , Sarcoma/pathology , Sensitivity and Specificity , Soft Tissue Neoplasms/diagnostic imaging , Software , Thyroid Neoplasms/diagnostic imaging , Thyroid Neoplasms/pathology
10.
Chirurg ; 79(1): 18, 20-5, 2008 Jan.
Article in German | MEDLINE | ID: mdl-18209982

ABSTRACT

There are absolute and relative indications for complete removal of the thymus gland. In the complex therapy of autoimmune-related myasthenia gravis, thymectomy plays a central role and is performed with relative indication. In case of thymoma with or without myasthenia, thymectomy is absolutely indicated. Thymus resection is further necessary for cases of hyperparathyroidism with ectopic intrathymic parathyroids or with certain forms of multiple endocrine neoplasia. The transcervical operation technique traditionally reflected the well-founded desire for minimal invasiveness for thymectomy. Due to the requirement of radicality however, most of these operations were performed using sternotomy. With the evolution of therapeutic thoracoscopy in thoracic surgery, several pure or extended minimally invasive operation techniques for thymectomy have been developed. At present uni- or bilateral, subxiphoid, and modified transcervical single or combination thoracoscopic techniques are in use. Recently a very precise new level of thoracoscopic operation technique was developed using robotic-assisted surgery. There are special advantages of this technique for thymectomy. An overview of the development and experiences with minimally invasive thymectomy is presented, including data from the largest series published so far.


Subject(s)
Myasthenia Gravis/surgery , Robotics , Thoracoscopy , Thymectomy/methods , Thymoma/surgery , Thymus Neoplasms/surgery , Female , Humans , Male , Minimally Invasive Surgical Procedures , Prospective Studies , Randomized Controlled Trials as Topic , Sternum/surgery
11.
Radiologe ; 48(3): 243-8, 2008 Mar.
Article in German | MEDLINE | ID: mdl-18210061

ABSTRACT

Computed tomography (CT) accounts for a significant proportion of radiation exposure patients are exposed to during diagnosis, which means that particularly strict indications need to be observed especially where children are concerned. Numerous factors influence the level of radiation exposure, only a few of which can be changed by the radiologist and radiographer. Sound knowledge of the links between technical implementation and the resultant image quality needed for the diagnosis can dramatically reduce the radiation patients are exposed to, which in turn has an influence on the indications. In the present paper the radiologist is given tools for optimisation of CT examinations in children and accepted indications for CT of all body regions are presented.


Subject(s)
Pediatrics/methods , Radiation Dosage , Radiation Injuries/etiology , Radiation Injuries/prevention & control , Radiation Protection/methods , Risk Assessment/methods , Tomography, X-Ray Computed/methods , Child , Humans , Relative Biological Effectiveness , Risk Factors
12.
Rofo ; 179(10): 1061-7, 2007 Oct.
Article in German | MEDLINE | ID: mdl-17786895

ABSTRACT

PURPOSE: Many patients dislike oral contrast media due to their bad taste. The aim of the present study was to identify a solution that tastes better while providing the same opacification in order to offer oncological patients an alternative to the routinely used bad tasting oral contrast media. MATERIALS AND METHODS: In a single blinded, prospective clinical study, the orally administered intravenous contrast media iohexol (Omnipaque), iopromide (Ultravist), and iotrolan (Isovist) as well as the oral contrast media sodium amidotrizoate (Gastrografin) and ioxithalamate (Telebrix) were each compared to the oral contrast medium lysine amidotrizoate as the reference standard at a constant dilution. The density values of all contrast media with the same dilutions were first measured in a phantom study. The patient study included 160 patients who had undergone a prior abdominal CT scan with lysine amidotrizoate within 6 months. The patients rated their subjective taste impression on a scale of 0 (very bad) to 10 (excellent). In addition, adverse events and opacification were recorded and prices were compared. RESULTS: The phantom study revealed identical density values. Patients assigned much higher taste impression scores of 8 and 7 to iohexol and iotrolan, respectively, as compared to a score of 3 for the conventional lysine amidotrizoate (p< 0.05). Iopromide and sodium amidotrizoate did not differ significantly from lysine amidotrizoate. The opacification of all contrast media and experienced adverse events did not differ significantly. Iotrolan (ca. 120 euro/100 ml), Iohexol and Iopromide (ca. 70 euro/100 ml) are more expensive than the conventional oral contrast media (ca. 10 - 20 euro/100 ml). CONCLUSION: Orally administered solutions of non-ionic contrast media improve patient comfort due to the better taste and provide the same opacification in comparison to conventional oral contrast media. At present, their use should be limited to individual cases due to the higher costs.


Subject(s)
Contrast Media/administration & dosage , Contrast Media/economics , Iohexol/administration & dosage , Iohexol/economics , Radiography, Abdominal , Taste , Tomography, X-Ray Computed , Triiodobenzoic Acids/administration & dosage , Triiodobenzoic Acids/economics , Administration, Oral , Adult , Aged , Aged, 80 and over , Data Interpretation, Statistical , Diatrizoate Meglumine/administration & dosage , Diatrizoate Meglumine/economics , Female , Humans , Injections, Intravenous , Intestine, Small/diagnostic imaging , Iohexol/analogs & derivatives , Male , Middle Aged , Patient Acceptance of Health Care , Phantoms, Imaging , Prospective Studies , Reference Standards
14.
Eur J Vasc Endovasc Surg ; 33(3): 302-5, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17097896

ABSTRACT

PURPOSE: To report the first successful endovascular repair of a non-aneurysmal aortic rupture due to periaortic tumour regression. CASE REPORT: A 58-year-old man developed spontaneous infrarenal aortic rupture following chemotherapy which led to regression of a periaortic mesothelioma that had been diagnosed during explorative laparotomy 11 months earlier. Stent-graft placement was performed with intentional conversion of a bifurcated (Zenith, COOK) into an aorto-uni-iliac system. No complications were encountered during a 40 months follow-up. CONCLUSION: Endovascular repair should be considered as a treatment option in non-aneurysmal aortic rupture.


Subject(s)
Antineoplastic Agents/adverse effects , Aortic Rupture/therapy , Blood Vessel Prosthesis Implantation , Mesothelioma/drug therapy , Peritoneal Neoplasms/drug therapy , Aortic Rupture/diagnostic imaging , Humans , Male , Middle Aged , Stents , Tomography, X-Ray Computed
15.
Acta Oncol ; 45(7): 881-9, 2006.
Article in English | MEDLINE | ID: mdl-16982554

ABSTRACT

To evaluate our initial experience with image guided respiratory gated H-SBRT for liver and lung tumors. The system combines a stereoscopic x-ray imaging system (ExacTrac X-Ray 6D) with a dedicated conformal stereotactic radiosurgery and radiotherapy linear accelerator (Novalis) and ExacTrac Adaptive Gating for dynamic adaptive treatment. Moving targets are located and tracked by x-ray imaging of implanted fiducial markers defined in the treatment planning computed tomography (CT). The marker position is compared with the position in verification stereoscopic x-ray images, using fully automated marker detection software. The required shift for a correct, gated set-up is calculated and automatically applied. We present our acceptance testing and initial experience in patients with liver and lung tumors. For treatment planning CT and Fluorodeoxyglucose-Positron Emission Tomography (FDG-PET) as well as magnetic resonance imaging (MRI) taken at free breathing and expiration breath hold with internal and external fiducials present were used. Patients were treated with 8-11 consecutive fractions to a dose of 74.8-79.2 Gy. Phantom tests demonstrated targeting accuracy with a moving target to within +/-1 mm. Inter- and intrafractional patient set-up displacements, as corrected by the gated set-up and not detectable by a conventional set-up, were up to 30 mm. Verification imaging to determine target location during treatment showed an average marker position deviation from the expected position of up to 4 mm on real patients. This initial evaluation shows the accuracy of the system and feasibility of image guided real-time respiratory gated H-SBRT for liver and lung tumors.


Subject(s)
Carcinoma/surgery , Liver Neoplasms/surgery , Lung Neoplasms/surgery , Radiosurgery/methods , Respiration , Surgery, Computer-Assisted/methods , Aged , Dose Fractionation, Radiation , Female , Humans , Male , Middle Aged , Movement/physiology , Phantoms, Imaging , Radiosurgery/instrumentation
17.
Zentralbl Chir ; 131(1): 8-12, 2006 Feb.
Article in German | MEDLINE | ID: mdl-16485203

ABSTRACT

INTRODUCTION: Endovascular therapy is being used increasingly also to treat ruptured infrarenal aortic aneurysms. Non-traumatic rupture of non-aneurysmatic infrarenal aorta is an absolute rarity. METHODS: The feasibility of endovascular repair of infrarenal aortic rupture is demonstrated with a case history and a literature review. RESULTS: A 58-year-old male developed spontaneous rupture of his infrarenal aorta after successful chemotherapy resulting in regression of a periaortic tumor. The patient suffered from a sepsis for several days before aortic rupture was discovered during computed tomography for focus search. Immediate endovascular stent-graft repair was performed under emergency conditions. There is no recurrence and the patient is doing well with the stent-graft in place without any pathological finding after a follow-up of 24 months. So far only three further cases have been reported of endovascular repair for penetrating atherosclerotic ulcer with rupture of the infrarenal aorta. DISCUSSION: This is the first report of endovascular repair of aortic rupture due to successful chemotherapy of a periaortic mesothelioma. Furthermore, this is the fourth case of successful stent-graft placement to treat non-aneurysmatic rupture of the infrarenal aorta. Minimally invasive endovascular therapy should become a standard treatment option for aortic rupture.


Subject(s)
Angioplasty, Balloon/methods , Aorta, Abdominal , Aortic Rupture/therapy , Stents , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Aorta, Abdominal/diagnostic imaging , Aortic Rupture/diagnostic imaging , Aortography , Blood Vessel Prosthesis Implantation , Emergencies , Humans , Mesothelioma/drug therapy , Middle Aged , Peritoneal Neoplasms/drug therapy , Postoperative Complications/diagnostic imaging , Postoperative Complications/therapy , Sepsis/complications , Sepsis/diagnosis , Staphylococcal Infections/complications , Staphylococcal Infections/diagnosis , Tomography, X-Ray Computed
18.
Nervenarzt ; 77(2): 231-8, 241; quiz 242-3, 2006 Feb.
Article in German | MEDLINE | ID: mdl-16283150

ABSTRACT

While magnetic resonance imaging (MRI) is the first line modality in depicting intramedullary spinal lesions, computed tomographic (CT) myelography has gained renewed attention due to the introduction of multislice scanning (MS-CT). Compared with conventional CT, MS-CT permits rapid, high-resolution imaging of various spinal pathologies with extended scan length. Although soft tissue contrast is inferior to that with MRI, MS-CT myelography performs best in detailed assessment of osseous pathologies, 3D imaging of orthopedic and anesthesiologic implants, and showing dural leakage and causes of CSF circulation impairment. Whenever MRI is not available or contraindicated, MS-CT myelography is the method of choice for evaluating spinal lesions.


Subject(s)
Imaging, Three-Dimensional/methods , Myelography/methods , Radiographic Image Interpretation, Computer-Assisted/methods , Spinal Cord Diseases/diagnostic imaging , Tomography, Spiral Computed/methods , Tomography, X-Ray Computed/methods , Anatomy, Cross-Sectional/methods , Humans , Practice Patterns, Physicians'
SELECTION OF CITATIONS
SEARCH DETAIL
...